Retrotype, Inc. Company
Retrotrope is changing aging as we know it, so that people do not have to suffer the ravages of many degenerative diseases. Retrotope is a pharmaceutical company startup that is leading the advance of a revolutionary new unified theory of cellular degeneration that can result in dramatically new approaches to therapy. This theory is based on three groundbreaking discoveries:
Many disparate degenerative diseases share a common weakness.
That weakness is one type of chemical bond that makes membrane fats susceptible to oxidation damage and loss of function.
By strengthening that bond, we are able to prevent and even reverse disease damage.
Number Of Exists:
N/A
Technology:
Preventive Medicine
Funding Status:
undisclosed
Investment Stage:
N/A
Industry:
Precision Medicine
Investor Type:
N/A
Founded Date:
2006
Headquarters:
Los Altos
Employee Number:
Undisclosed